ZRANB1 and breast cancer: Based on the result of a previous study, we found that binding of zinc finger RANBP2-type containing 1 (ZRANB1) to EZH2 led to EZH2 deubiquitination, thereby stabilizing EZH2 protein expression in breast cancer [25].